News and Press Releases
Promega Corporation is a global biotechnology company headquartered in Madison, WI, with branches in 16 countries. Our products and technologies are used to support scientific advances in academic, pharmaceutical, clinical, forensic and industrial/environmental labs worldwide.
Company-Wide News
2022
2022 International Symposium on Human Identification (ISHI) Keynote DeNeen L. Brown Outlines Search for Victims of 1921 Tulsa Race MassacreAugust 9 • 3 min read
Renewable Sources Now Supplying Over 20% of Promega Global Electricity UseJune 8 • 3 min read
Forensic Laboratories Gain Unique Flexibility with Spectrum CE SystemMay 17 • 2 min read
Researchers Studying Inflammation Can Simplify Cytokine Detection with New Promega Lumit™ ImmunoassaysMarch 30 • 2 min read
Promega to Launch Post-Doctoral Research Program to Develop New Tools for Genome EditingMarch 29 • 2 min read
Promega Named One of Madison, Wisconsin's Top Workplaces 2022March 28 • 2 min read
New Study Reveals Strategies for Targeting “Undruggable” KRAS MutantsMarch 21 • 2 min read
Promega Corporation and FUJIFILM Cellular Dynamics Announce Strategic Collaboration to Advance Novel Assay DevelopmentMarch 10 • 3 min read
Promega Earns a 2022 Top Workplaces USA AwardFebruary 1 • 1 min read
2021
Research Reveals Trivalent PROTACs More Potent in Targeted Protein DegradationOctober 21 • 2 min read
Promega Launches Sanger Sequencing Chemistry Compatible With All Capillary Electrophoresis PlatformsOctober 19 • 3 min read
Promega Launches OncoMate™ MSI Dx Analysis System in USSeptember 8 • 2 min read
Applications of Bioluminescent Research Tools Showcased at Global Seminar SeriesAugust 24 • 2 min read
Wastewater Testing Labs Can Detect SARS-CoV-2 in Less Than Four Hours with New MethodsAugust 16 • 2 min read
Commitment to World Trade Center Victim Identification: 2021 International Symposium on Human Identification (ISHI) Spotlights 9/11 Response & Ongoing AdvancesAugust 11 • 2 min read
Promega and Henlius Developing Microsatellite Instability Companion Diagnostic IVD Kit for Serplulimab in ChinaAugust 5 • 3 min read
FDA Clears Promega OncoMate™ MSI Dx Analysis SystemJuly 28 • 3 min read
Promega 2021 Corporate Responsibility Report Sets 2030 Sustainability Targets; Spotlights COVID-19 ResponseJune 23 • 3 min read
Biotech and Pharma Labs Performing Endpoint PCR Can Reduce Amplification Time to 15 Minutes with New Promega Reagent and Eppendorf Instrument CombinationJune 8 • 3 min read
Promega, Exact Sciences Partnering to Help Jumpstart Colorectal Cancer ScreeningsMay 10 • 1 min read
Promega Opens New Research & Development Facility Supporting Science at the Edge of InnovationApril 6 • 3 min read
Consciousness of Connection – Awakening from Despair to Awe: 2021 International Forum on Consciousness to Explore Connections That Support Mutual FlourishingMarch 31 • 2 min read
Promega Biotech Ibérica Earns Recognition for COVID-19 Response in SpainMarch 23 • 2 min read
Drug Developers Can Measure ADCC in Biologically Relevant Systems with New Promega Bioluminescent Primary Cell BioassayMarch 3 • 2 min read
Cancer Researchers Can Assess Microsatellite Instability (MSI) Through New Lens with Expanded Promega SystemFebruary 17 • 2 min read
Promega Assisting Wisconsin COVID-19 Vaccination EffortFebruary 9 • 2 min read
Combined CDC COVID-19/Influenza Test Amended to Include Promega Maxwell® RSC 48 and CSC 48 Instruments, Maxwell® RSC Viral Total Nucleic Acid Purification KitJanuary 13 • 2 min read
2020
Largest Solar Array in Dane County Will Help Power PromegaOctober 1 • 2 min read
Promega Developing OncoMate™ MSI Assay as Companion Diagnostic for Endometrial Cancer Drug Candidate from IncyteSeptember 22 • 2 min read
DNA experts gather to advance forensic science at 2020 International Symposium on Human IdentificationSeptember 14 • 2 min read
"At a time when some find the needs in our world overwhelming, individual efforts may feel futile, and yet, the influence of an individual is just what we need."
—William A. Linton, Chairman & CEO